肿瘤防治研究2024，Vol.51Issue(6)：409-418,10.DOI:10.3971/j.issn.1000-8578.2024.24.0090
晚期非小细胞肺癌免疫治疗:研究进展和展望
Immunotherapy for Advanced Non-small Cell Lung Cancer:Research Progress and Perspectives
摘要
Abstract
Immunotherapy has changed the treatment landscape of advanced non-small cell lung cancer(NSCLC),showing great potential in the treatment of untreated and relapsed or refractory(R/R)patients.However,numerous issues that need further exploration remain with the wide application of immunotherapy.They include the exploration of biomarkers for efficacy prediction,the optimization of immunotherapy modalities,immune-related adverse effects,and the management of special populations.This review summarizes the progress of the research on immunotherapy for advanced NSCLC and discusses its challenges and future directions.关键词
非小细胞肺癌/免疫治疗/免疫检查点抑制剂Key words
Non-small cell lung cancer/Immunotherapy/Immune checkpoint inhibitors分类
医药卫生引用本文复制引用
王婧怡,钟雨玲,邬麟..晚期非小细胞肺癌免疫治疗:研究进展和展望[J].肿瘤防治研究,2024,51(6):409-418,10.基金项目
湖南省科技创新计划(2023SK4024、2021SK51121) （2023SK4024、2021SK51121）
湖南省肿瘤医院"科研攀登计划"(2X2020005-5) （2X2020005-5）
北京市希思科临床肿瘤学研究基金会(Y-2019Gene-cast-024) The Science and Technology Innovation Program of Hunan Province(No.2023SK4024,No.2021SK51121) （Y-2019Gene-cast-024）
Hunan Cancer Hospital Climb Plan(No.2X2020005-5) （No.2X2020005-5）
Beijing Xisike Clinical Oncology Research Foundation(No.Y-2019Genecast-024) （No.Y-2019Genecast-024）
